What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Cancer
Her primary scientific interests are in Internal medicine, Fatty liver, Nonalcoholic fatty liver disease, Endocrinology and Gastroenterology.
Steatosis, Liver disease, Cirrhosis, Insulin resistance and Steatohepatitis are among the areas of Internal medicine where Anna Mae Diehl concentrates her study.
Anna Mae Diehl interconnects Chronic liver disease, Ethanol, Surgery and Hepatocyte in the investigation of issues within Fatty liver.
Her work carried out in the field of Nonalcoholic fatty liver disease brings together such families of science as Fibrosis, Hepatic fibrosis, Hepatology, Alanine transaminase and MAPK/ERK pathway.
The various areas that Anna Mae Diehl examines in her Endocrinology study include Fructose and Fatty acid.
Her Gastroenterology research incorporates themes from Body mass index, Biopsy, Liver biopsy, Hepatitis and Disease.
Her most cited work include:
- The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2680 citations)
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (2082 citations)
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (1368 citations)
What are the main themes of her work throughout her whole career to date?
Anna Mae Diehl spends much of her time researching Internal medicine, Endocrinology, Gastroenterology, Nonalcoholic fatty liver disease and Fatty liver.
Steatosis, Fibrosis, Liver disease, Cirrhosis and Liver injury are the primary areas of interest in her Internal medicine study.
Her Endocrinology research incorporates elements of Hepatocyte and Liver regeneration.
Her Gastroenterology study combines topics in areas such as Nonalcoholic steatohepatitis and Biopsy, Liver biopsy.
Her study in Nonalcoholic fatty liver disease is interdisciplinary in nature, drawing from both Body mass index, Hepatic fibrosis, Diabetes mellitus, Metabolic syndrome and Inflammation.
Her Fatty liver research is mostly focused on the topic Steatohepatitis.
She most often published in these fields:
- Internal medicine (56.13%)
- Endocrinology (32.34%)
- Gastroenterology (22.12%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (56.13%)
- Gastroenterology (22.12%)
- Nonalcoholic fatty liver disease (21.00%)
In recent papers she was focusing on the following fields of study:
Anna Mae Diehl focuses on Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fibrosis and Cancer research.
Her research in Internal medicine tackles topics such as Endocrinology which are related to areas like Liver cancer.
The Gastroenterology study combines topics in areas such as Biopsy, Liver biopsy and Pathology.
Her research on Nonalcoholic fatty liver disease also deals with topics like
- Inflammation which connect with Oxidative stress,
- Insulin resistance and Prospective cohort study most often made with reference to Metabolic syndrome.
Her studies in Fibrosis integrate themes in fields like Receptor, Osteopontin, Liver injury and Confidence interval.
Her Cancer research study combines topics from a wide range of disciplines, such as Hepatic stellate cell, Downregulation and upregulation and Hepatocyte.
Between 2015 and 2021, her most popular works were:
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. (575 citations)
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis (435 citations)
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial (299 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
Her scientific interests lie mostly in Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fibrosis and Fatty liver.
Internal medicine is often connected to Endocrinology in her work.
Her Gastroenterology research includes elements of Biopsy, Liver biopsy, Magnetic resonance imaging and Liver injury.
She has included themes like Odds ratio, Steatosis and Gut flora in her Nonalcoholic fatty liver disease study.
Her Fibrosis research integrates issues from Osteopontin, Hepatology and Confidence interval.
She has researched Fatty liver in several fields, including Inflammation, Immunology, Oxidative stress and Chronic liver disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
